A citation-based method for searching scientific literature

Chintal H Shah, Rajesh Balkrishnan, Vakaramoko Diaby, Hong Xiao. Res Social Adm Pharm 2020
Times Cited: 2







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Breast cancer statistics, 2019.
Carol E DeSantis, Jiemin Ma, Mia M Gaudet, Lisa A Newman, Kimberly D Miller, Ann Goding Sauer, Ahmedin Jemal, Rebecca L Siegel. CA Cancer J Clin 2019
50

Characteristics associated with differences in survival among black and white women with breast cancer.
Jeffrey H Silber, Paul R Rosenbaum, Amy S Clark, Bruce J Giantonio, Richard N Ross, Yun Teng, Min Wang, Bijan A Niknam, Justin M Ludwig, Wei Wang,[...]. JAMA 2013
199
50

Factors That Contributed to Black-White Disparities in Survival Among Nonelderly Women With Breast Cancer Between 2004 and 2013.
Ahmedin Jemal, Anthony S Robbins, Chun Chieh Lin, W Dana Flanders, Carol E DeSantis, Elizabeth M Ward, Rachel A Freedman. J Clin Oncol 2018
78
50

Revisiting the definition of estrogen receptor positivity in HER2-negative primary breast cancer.
T Fujii, T Kogawa, W Dong, A A Sahin, S Moulder, J K Litton, D Tripathy, T Iwamoto, K K Hunt, L Pusztai,[...]. Ann Oncol 2017
58
50

Racial disparities in treatment patterns and clinical outcomes in patients with HER2-positive metastatic breast cancer.
Hope S Rugo, Adam M Brufsky, Marianne Ulcickas Yood, Debu Tripathy, Peter A Kaufman, Musa Mayer, Bongin Yoo, Oyewale O Abidoye, Denise A Yardley. Breast Cancer Res Treat 2013
27
50

American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer.
M Elizabeth H Hammond, Daniel F Hayes, Mitch Dowsett, D Craig Allred, Karen L Hagerty, Sunil Badve, Patrick L Fitzgibbons, Glenn Francis, Neil S Goldstein, Malcolm Hayes,[...]. J Clin Oncol 2010
50

Mortality risk of black women and white women with invasive breast cancer by hormone receptors, HER2, and p53 status.
Huiyan Ma, Yani Lu, Kathleen E Malone, Polly A Marchbanks, Dennis M Deapen, Robert Spirtas, Ronald T Burkman, Brian L Strom, Jill A McDonald, Suzanne G Folger,[...]. BMC Cancer 2013
33
50

Steroid-hormone receptors and survival after first relapse in breast cancer.
A Howell, D M Barnes, R N Harland, J Redford, V H Bramwell, M J Wilkinson, R Swindell, D Crowther, R A Sellwood. Lancet 1984
168
50

Breast cancer version 3.2014.
William J Gradishar, Benjamin O Anderson, Sarah L Blair, Harold J Burstein, Amy Cyr, Anthony D Elias, William B Farrar, Andres Forero, Sharon Hermes Giordano, Lori J Goldstein,[...]. J Natl Compr Canc Netw 2014
142
50

Adherence to tamoxifen over the five-year course.
Timothy L Lash, Matthew P Fox, Jennifer L Westrup, Aliza K Fink, Rebecca A Silliman. Breast Cancer Res Treat 2006
247
50


Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer.
Ann H Partridge, Philip S Wang, Eric P Winer, Jerry Avorn. J Clin Oncol 2003
489
50

Quantitative measures of estrogen receptor expression in relation to breast cancer-specific mortality risk among white women and black women.
Huiyan Ma, Yani Lu, Polly A Marchbanks, Suzanne G Folger, Brian L Strom, Jill A McDonald, Michael S Simon, Linda K Weiss, Kathleen E Malone, Ronald T Burkman,[...]. Breast Cancer Res 2013
26
50


Breast Cancer Mortality in African-American and Non-Hispanic White Women by Molecular Subtype and Stage at Diagnosis: A Population-Based Study.
Li Tao, Scarlett Lin Gomez, Theresa H M Keegan, Allison W Kurian, Christina A Clarke. Cancer Epidemiol Biomarkers Prev 2015
70
50


Intrinsic breast tumor subtypes, race, and long-term survival in the Carolina Breast Cancer Study.
Katie M O'Brien, Stephen R Cole, Chiu-Kit Tse, Charles M Perou, Lisa A Carey, William D Foulkes, Lynn G Dressler, Joseph Geradts, Robert C Millikan. Clin Cancer Res 2010
270
50

Racial disparities in the rate of cardiotoxicity of HER2-targeted therapies among women with early breast cancer.
Anya Litvak, Bhavina Batukbhai, Stuart D Russell, Hua-Ling Tsai, Gary L Rosner, Stacie C Jeter, Deborah Armstrong, Leisha A Emens, John Fetting, Antonio C Wolff,[...]. Cancer 2018
23
50


Literature review of data-based models for identification of factors associated with racial disparities in breast cancer mortality.
Diana Prieto, Milton Soto-Ferrari, Rindy Tija, Lorena Peña, Leandra Burke, Lisa Miller, Kelsey Berndt, Brian Hill, Jafar Haghsenas, Ethan Maltz,[...]. Health Syst (Basingstoke) 2018
1
100

Poor prognosis of single hormone receptor- positive breast cancer: similar outcome as triple-negative breast cancer.
Soo Youn Bae, Sangmin Kim, Jun Ho Lee, Hyun-Chul Lee, Se Kyung Lee, Won Ho Kil, Seok Won Kim, Jeong Eon Lee, Seok Jin Nam. BMC Cancer 2015
78
50

Prognostic factors predicting survival from first recurrence in patients with metastatic breast cancer: analysis of 439 patients.
A Insa, A Lluch, F Prosper, I Marugan, A Martinez-Agullo, J Garcia-Conde. Breast Cancer Res Treat 1999
131
50

Borderline Estrogen Receptor-Positive Breast Cancers in Black and White Women.
Halei C Benefield, Emma H Allott, Katherine E Reeder-Hayes, Charles M Perou, Lisa A Carey, Joseph Geradts, Xuezheng Sun, Benjamin C Calhoun, Melissa A Troester. J Natl Cancer Inst 2020
4
50


Trastuzumab-induced cardiomyopathy: incidence and associated risk factors in an inner-city population.
Kaitlin B Baron, Jennifer R Brown, Brian L Heiss, Joanne Marshall, Nancy Tait, Katherine H R Tkaczuk, Stephen S Gottlieb. J Card Fail 2014
19
50

Racial/Ethnic and socioeconomic disparities in endocrine therapy adherence in breast cancer: a systematic review.
Megan C Roberts, Stephanie B Wheeler, Katherine Reeder-Hayes. Am J Public Health 2015
68
50


Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer.
Dawn L Hershman, Theresa Shao, Lawrence H Kushi, Donna Buono, Wei Yann Tsai, Louis Fehrenbacher, Marilyn Kwan, Scarlett Lin Gomez, Alfred I Neugut. Breast Cancer Res Treat 2011
512
50

Perceived barriers to treatment predict adherence to aromatase inhibitors among breast cancer survivors.
Moriah J Brier, Dianne L Chambless, Robert Gross, Jinbo Chen, Jun J Mao. Cancer 2017
23
50


Medication adherence: WHO cares?
Marie T Brown, Jennifer K Bussell. Mayo Clin Proc 2011
872
50

Determinants affecting medication adherence in the elderly: A qualitative study.
Peivand Bastani, Parisa Bikineh, Ramin Ravangard, Rita Rezaee, Zahra Kavosi. Aging Med (Milton) 2020
1
100


Adherence to adjuvant hormone therapy in low-income women with breast cancer: the role of provider-patient communication.
Yihang Liu, Jennifer L Malin, Allison L Diamant, Amardeep Thind, Rose C Maly. Breast Cancer Res Treat 2013
88
50


How patients experience endocrine therapy for breast cancer: an online survey of side effects, adherence, and medical team support.
Maurice J Berkowitz, Carlie K Thompson, Laura T Zibecchi, Minna K Lee, Elani Streja, Jacob S Berkowitz, Cachet M Wenziger, Jennifer L Baker, Maggie L DiNome, Deanna J Attai. J Cancer Surviv 2021
11
50

Aromatase inhibitors in breast cancer.
Ian E Smith, Mitch Dowsett. N Engl J Med 2003
585
50


Cohort study of adherence to adjuvant endocrine therapy, breast cancer recurrence and mortality.
B Makubate, P T Donnan, J A Dewar, A M Thompson, C McCowan. Br J Cancer 2013
164
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.